Literature DB >> 8308775

Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.

P Cherin1, J C Piette, S Herson, O Bletry, B Wechsler, C Frances, P Godeau.   

Abstract

The relationship between malignancy and inflammatory myopathies is now statistically well established. However, the link between polymyositis (PM) or dermatomyositis (DM) and ovarian cancer (OC) has never been clearly emphasized. OC is the 6th most frequent malignancy, occurring in about 1% of the general female population. We describe 7 cases of DM associated with OC (proven in 6 patients, and very probable in a 7th), in a series of 140 adult inflammatory myopathies followed in our institution [84 PM and 56 DM (including 45 female)]. Twenty-four patients had associated malignancy (12 PM and 12 DM). Without considering the probable case, OC occurred in 13.3% (6/45) of the total female DM population, a much higher rate than the 1% observed in the general female population; and in 21.4% (6/28) of females aged over 40 with DM. In women over 40 with DM, ovarian cancer has a major position among associated internal malignancies, and has to be adequately looked for by physicians.

Entities:  

Mesh:

Year:  1993        PMID: 8308775

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 2.  Malignancy in myositis.

Authors:  Zaki Abou Zahr; Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

3.  Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review of the literature.

Authors:  I Kalogiannidis; A Papanikolaou; I Xanthakis; A Makedos; N Prapas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

4.  Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin.

Authors:  Zachary Raizman; Boshra Hosseini; Sarah Kean; Alon D Altman
Journal:  Gynecol Oncol Rep       Date:  2017-04-05

5.  Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis.

Authors:  Hongyan Cheng; Lanqing Huo; Dan Wang; Yang Xiang
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

6.  [Dermatomyositis in the elderly: a study of 4 cases in southern Tunisia].

Authors:  Faten Frikha; Mouna Snoussi; Raida Ben Salah; Noura Saidi; Neila Kaddour; Zouhir Bahloul
Journal:  Pan Afr Med J       Date:  2012-10-06

7.  Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.

Authors:  Alan Christie; Neil McKay; Fiona Nussey
Journal:  Gynecol Oncol Case Rep       Date:  2013-07-16

8.  Paraneoplastic Raynaud phenomenon associated with metastatic ovarian cancer: A case report and review of the literature.

Authors:  Tiffany S Lai; Man R Shim; David Shin; Mae Zakhour
Journal:  Gynecol Oncol Rep       Date:  2020-04-26

Review 9.  Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.

Authors:  Aleksandra H Opinc; Joanna S Makowska
Journal:  Biomolecules       Date:  2022-01-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.